BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018
Scientific Program
 
BIT's 16th Annual Congress of International Drug Discovery Science and Technology-2018
Theme: Rethinking the Next Big Things in Pharma Innovations
Time: August 16-19, 2018 
Place: Boston Marriott Cambridge, USA
 
Scientific Program
Stream 1 Stream 2 Stream 3 Stream 4 Stream 5

 

Stream 3: Industrial Art Gallery
-Arts in Billion Dollar Molecules and Next Generation Therapy

Substream 3-1: Improved Linear Drug Discovery on Selected Current Drug Targets
Substream 3-2: Novel Small Molecule Inhibitors and Agonists
Substream 3-3: Follow-on Drugs and Repositioning Drug Discovery
Substream 3-4: Novel Biotherapeutic Discovery
Substream 3-5: Smart DDS and Nanomedicine

Substream 3-6: Clinical Trial Gateway and Translational Convergence

Substream 3-7: Arts of Next Generation Therapy

 

Substream 3-5: Smart DDS and Nanomedicine
 

Session 3501: Nanotechnology for Drug Delivery and Nanomedicine

Day 2: Morning, Friday, August 17, 2018

Place: Endeavor Room, 3rd Floor

08:30-12:10

Chair: Dr. Robert W. Lee, President, Particle Sciences, a Lubrizol Advanced Materials, Inc., USA
Co-Chair: Dr. Deepak Hegde, Director-Global external Development & Supply-Asiapacific, GSK Shanghai R & D, China
Time FaceOn Speeches and Speakers
08:30-08:35 Chair's Introduction
08:35-09:00

Title: Opportunities for Sterile Nanoparticulate Suspensions

Dr. Robert W. Lee, President, Particle Sciences, a Lubrizol Advanced Materials, Inc., USA
09:00-09:25

Title: Conjugated Polymer Thin Films for Photo-thermal Treatment of Cells

Dr. Eunkyoung Kim, Director, Active Polymer Center for Pattern Integration, Yonsei University, South Korea

09:25-09:50 Title: Two Decades of Commercializing Nanomedicine: Improving Health One Giant Nanostep at a Time
Dr. Thomas J. Webster, Art Zafiropoulo Chair and Department Chair, Department of Chemical Engineering, Northeastern University, USA
09:50-10:15 Title: Biomedical Nanotechnology: The Smaller the Thing, the Bigger the Challenge™
Dr. Michael Drues, President, Vascular Sciences, USA
10:15-10:30 Coffee Break
10:30-10:55

Title: Drug Delivery via Nanoparticles

Dr. Deepak Hegde, Director-Global external Development & Supply-Asiapacific, GSK Shanghai R & D, China 

10:55-11:20 Title: Inflammation Responsive Hydrogel Platform for Controlled Drug Delivery
Dr. Nitin Joshi, Instructor in Medicine, Harvard Medical School; Associate Bioengineer, Brigham and Women's Hospital, USA
11:20-11:45 Title: Progress in Smart Nanopolymeric Platforms for Drug Delivery and Tumor Treatment
Dr. Majid Hosseini, Lecturer, Manufacturing and Industrial Engineering Department, The University of Texas Rio Grande Valley, USA
11:45-12:10

Title: Gold Nanorods Conjugated Porous Silicon Nanoparticles Functionalized Calcium Alginate Nano Hydrogels as Therapeutics Co-delivery Nanocarrier for Biomedical Applications

Dr. Mingtan Hai, Visiting Professor, Harvard John A. Paulson School of Engineering and Applied Science, Harvard University, USA

 

Session 3502: Formulation and Smart DDS

Day 3: Morning, Saturday, August 18, 2018

Place: Endeavor Room, 3rd Floor

08:30-12:10

Chair: Dr. Kevin P. O’Donnell, R & D Manager, Dow Chemical Company, USA

Co-Chair: Dr. Donovan B. Yeates, Chief Executive Officer, KAER Biotherapeutics Corporation, USA

Time FaceOn Speeches and Speakers
08:30-08:35 Chair's Introduction
08:35-08:55  

 Keynote Speech

Title: 3D Printed Scaffolds and Implants in Drug Delivery for Bone Disorders

Dr. Susmita Bose, Herman and Brita Lindholm Endowed Chair Professor, School of Mechanical and Materials Engineering, Washington State University, USA
08:55-09:15

Title: Cellulosic Excipient Chemistry Redesigned to Meet Current Drug Delivery Needs

Dr. Kevin P. O’Donnell, R & D Manager, DowDuPont Specialty Products Division, Dow Chemical Company, USA

09:15-09:35 Title: Employing Cellular Protein Trafficking for Selective Delivery of Cytotoxic Drugs into FGFR1-overproducing Cancer Cells
Dr. Lukasz Opalinski, Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, Poland
09:35-09:55 Title: Sublingual Methadone: An Efficient Route of Administration for Cancer Pain
Dr. Ricardo Cunha, Professor of Pain Medicine, Federal University of Rio de Janeiro, Brazil
09:55-10:15 Title: Development of Transdermal Delivery System of Duloxetine
Dr. Yasuko Obata, Professor and Chairperson, Department of Pharmaceutics, Hoshi University, Japan
10:15-10:30 Coffee Break
10:30-10:50

Title: Recent Advances and Challenges in Non-invasive Oral Drug Delivery Platforms

Dr. Kiana Aran, Assistant Professor, Keck Graduate Institute, Claremont University, USA
10:50-11:10

Title: Drug Delivery to the Lung Using New Generation Dry Powder Inhaler

Dr. Guy Steuer, Head, Aerosol Medicine Society, Israel

11:10-11:30 Title: Physical Stability of Salts of Weak Bases in Drug Product
Dr. Sweta Modi, Principal Scientist, Pfizer Inc., USA
11:30-11:50

Title: Delivery of Aerosolized Biologics at High Dose Rates

Dr. Donovan B. Yeates, Chief Executive Officer, KAER Biotherapeutics Corporation, USA

11:50-12:10  

Title: Preclinical Sheep Models for the Study of Pulmonary Disease and Drug Delivery

Dr. Rob Bischof, Chief Scientific Officer, Allergenix Pty Ltd.; Senior Research Scientist, Hudson Institute of Medical Research, Australia
12:00-13:00 Lunch

  

© 2003-2018 All rights reserved by BITeomics Inc.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897